Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of MLN8237 in Patients With Advanced Hematological Malignancies
This study is ongoing, but not recruiting participants.
Study NCT00697346 Information provided by Millennium Pharmaceuticals, Inc.
First Received on June 11, 2008. Last Updated on January 23, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
B-cell Follicular Lymphoma
B-cell Marginal Zone Lymphoma
Diffuse Large B-cell Lymphoma
B-cell Mantle Cell Lymphoma
Multiple Myeloma
Waldenstrom's Macroglobulinemia
Anaplastic Large Cell Lymphoma
NK Lymphoma (NKL)
Additional conditions recognized in this trial
Enteropathy-Associated T-Cell Lymphoma
Hematologic Neoplasms
Immunoblastic Lymphadenopathy
Intestinal Diseases
Leukemia
Leukemia, Lymphocytic, Chronic, B-Cell
Leukemia, Lymphoid
Lymphoma
Lymphoma, B-Cell
Lymphoma, B-Cell, Marginal Zone
Lymphoma, Follicular
Lymphoma, Large B-Cell, Diffuse
Lymphoma, Large-Cell, Anaplastic
Lymphoma, Mantle-Cell
Lymphoma, Non-Hodgkin
Lymphoma, T-Cell
Lymphoma, T-Cell, Peripheral
Neoplasms, Plasma Cell
Waldenstrom Macroglobulinemia
More general conditions related to this trial
Blood Protein Disorders
Cardiovascular Diseases
Digestive System Diseases
Gastrointestinal Diseases
Hematologic Diseases
Hemorrhagic Disorders
Hemostatic Disorders
Immune System Diseases
Immunoproliferative Disorders
Leukemia, B-Cell
Lymphatic Diseases
Lymphoproliferative Disorders
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Paraproteinemias
Vascular Diseases
Interventions listed in this trial
MLN8237
Sponsors listed in this trial
Millennium Pharmaceuticals, Inc.
Back to top of Main Content
